Hanyang Med Rev.  2015 Nov;35(4):190-195. 10.7599/hmr.2015.35.4.190.

Induced Pluripotent Stem Cells: Next Generation Stem Cells to Clinical Applications

Affiliations
  • 1Department of Surgery, Hanyang University College of Medicine, Seoul, Korea.
  • 2Laboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological & Medical Science, Seoul, Korea. sblee@kirams.re.kr

Abstract

Induced pluripotent stem cells (iPSC) are specially manipulated cells from somatic cells by the introduction of four factors that are reprogrammed. The properties of iPSC are similar to embryonic stem cells (ESC) characteristic of self-renewal and pluripotency. The technology of reprogramming somatic cells to iPSC enables the generation of patient-specific cells that can be used as powerful tools for drug screening, in vitro models for human disease and autologous transplantation. The iPSC technology provides a priceless resource for regenerative medicine but there are still changing obstacles over the safety of iPSC in avoiding induction of tumorigenicity and maintaining high purity of re-differentiated cells from iPSC to produce more functional cells for cell therapy. A variety of methods to overcome the limitation of iPSC application applied in the clinical setting have been developed. In this review, we summarize the recent progress in iPSC generation and differentiation techniques to facilitate clinical application of iPSC with future potential in regenerative medicine.

Keyword

Induced Pluripotent Stem Cells (iPSC); Cellular Reprogramming; Regenerative Medicine

MeSH Terms

Autografts
Cell- and Tissue-Based Therapy
Drug Evaluation, Preclinical
Embryonic Stem Cells
Humans
Induced Pluripotent Stem Cells*
Regenerative Medicine
Stem Cells*
Transplantation, Autologous
Full Text Links
  • HMR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error